NASDAQ:XRAY - DENTSPLY SIRONA Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $64.00
  • Forecasted Upside: -0.11 %
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.29 (-0.45%)

This chart shows the closing price for XRAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DENTSPLY SIRONA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XRAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XRAY

Analyst Price Target is $64.00
▼ -0.11% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $64.00, with a high forecast of $78.00 and a low forecast of $47.00. The average price target represents a -0.11% upside from the last price of $64.07.

This chart shows the closing price for XRAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in DENTSPLY SIRONA. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2021Barrington ResearchBoost Price TargetOutperform$71.00 ➝ $77.00Low
5/7/2021Robert W. BairdBoost Price TargetOutperform$71.00 ➝ $78.00Medium
5/7/2021HC WainwrightBoost Price TargetNeutral$60.00 ➝ $72.00Medium
5/6/2021Piper SandlerBoost Price TargetOverweight$70.00 ➝ $75.00Medium
3/2/2021BarclaysBoost Price TargetUnderweight$50.00 ➝ $55.00Medium
3/2/2021Robert W. BairdBoost Price TargetOutperform$62.00 ➝ $71.00Medium
3/2/2021Barrington ResearchUpgradeMarket Perform ➝ Outperform$71.00Medium
3/2/2021HC WainwrightReiterated RatingNeutral$55.00 ➝ $60.00Low
3/1/2021Piper SandlerBoost Price TargetOverweight$63.00 ➝ $70.00Low
1/5/2021Robert W. BairdBoost Price TargetOutperform$58.00 ➝ $62.00N/A
1/5/2021BarclaysBoost Price TargetUnderweight$40.00 ➝ $44.00N/A
1/5/2021HC WainwrightBoost Price TargetNeutral$49.00 ➝ $55.00N/A
12/18/2020Stifel NicolausDowngradeBuy ➝ Hold$52.00Low
12/15/2020Piper SandlerBoost Price TargetOverweight$51.00 ➝ $61.00High
11/17/2020BarclaysDowngradeEqual Weight ➝ Underweight$40.00Low
11/9/2020HC WainwrightBoost Price TargetNeutral$45.00 ➝ $49.00High
10/22/2020GuggenheimUpgradeNeutral ➝ BuyHigh
10/5/2020JPMorgan Chase & Co.Boost Price TargetNeutral$45.00 ➝ $47.00Medium
8/10/2020HC WainwrightLower Price TargetNeutral$50.00 ➝ $45.00Low
7/20/2020Bank of AmericaBoost Price TargetBuy$54.00 ➝ $56.00Medium
6/16/2020Piper SandlerInitiated CoverageOverweight$51.00Low
6/15/2020HC WainwrightBoost Price TargetNeutral$38.00 ➝ $50.00Medium
5/27/2020Evercore ISIUpgradeIn-Line ➝ Outperform$50.00High
5/14/2020CfraLower Price TargetHold$53.00 ➝ $38.00High
5/11/2020BarclaysLower Price TargetEqual Weight$42.00 ➝ $40.00High
5/11/2020UBS GroupLower Price TargetNeutral$59.00 ➝ $44.00High
5/11/2020Barrington ResearchDowngradeOutperform ➝ Market PerformLow
4/24/2020HC WainwrightLower Price TargetNeutral$51.00 ➝ $38.00Medium
4/19/2020Credit Suisse GroupReiterated RatingBuy$50.00Low
4/19/2020Robert W. BairdUpgradeNeutral ➝ OutperformLow
4/8/2020Robert W. BairdUpgradeNeutral ➝ Outperform$57.00 ➝ $49.00Medium
4/7/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$58.00 ➝ $40.00Medium
4/2/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$66.00Low
3/17/2020JPMorgan Chase & Co.Lower Price TargetNeutral$65.00 ➝ $45.00High
3/13/2020Stifel NicolausLower Price TargetBuy$66.00 ➝ $56.00Low
3/11/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyLow
3/3/2020Barrington ResearchLower Price TargetOutperform$63.00 ➝ $60.00Medium
3/3/2020Robert W. BairdLower Price TargetNeutral$61.00 ➝ $57.00High
3/3/2020HC WainwrightReiterated RatingNeutral$60.00 ➝ $51.00High
2/19/2020Stifel NicolausBoost Price TargetBuy$63.00 ➝ $66.00Medium
1/19/2020BarclaysReiterated RatingHold$64.00Medium
12/11/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$65.00Low
11/15/2019HC WainwrightReiterated RatingHold$60.00Low
8/5/2019Barrington ResearchReiterated RatingBuy$63.00High
8/2/2019Wellington ShieldsUpgradeHold ➝ Gradually AccumulateHigh
7/26/2019Evercore ISIInitiated CoverageIn-line ➝ In-LineLow
7/9/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$55.00 ➝ $57.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/6/2019Barrington ResearchUpgradeMarket Perform ➝ Outperform$63.00Medium
5/6/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$49.00 ➝ $55.00Low
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$54.00High
4/5/2019HC WainwrightSet Price TargetHold$49.00Low
3/18/2019Bank of AmericaInitiated CoverageBuy$57.00Low
3/18/2019William BlairUpgradeMarket Perform ➝ Outperform$56.71Medium
3/12/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $53.00Low
3/4/2019Robert W. BairdBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $50.00Medium
3/4/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$40.00 ➝ $49.00Low
3/1/2019William BlairUpgradeMarket Perform ➝ OutperformLow
3/1/2019BarclaysSet Price TargetHold$49.00Low
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$42.00Low
1/6/2019BarclaysReiterated RatingHold$39.00Medium
11/9/2018Barrington ResearchReiterated RatingHoldMedium
10/19/2018The Goldman Sachs GroupUpgradeSell ➝ Buy$44.00High
8/31/2018HC WainwrightSet Price TargetHold$40.00Medium
8/9/2018Barrington ResearchDowngradeOutperform ➝ Market PerformLow
8/8/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $41.00Medium
8/8/2018Jefferies Financial GroupLower Price TargetBuy ➝ Buy$58.00 ➝ $46.00Medium
8/8/2018Stifel NicolausLower Price TargetBuy ➝ Buy$57.00 ➝ $46.00Medium
8/8/2018HC WainwrightReiterated RatingHold$40.00Medium
8/8/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$54.00 ➝ $40.00Medium
8/8/2018StephensDowngradeOverweight ➝ Equal Weight$75.00Medium
8/7/2018Robert W. BairdDowngradeOutperform ➝ Neutral$56.00 ➝ $38.00High
6/14/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$65.00 ➝ $54.00Low
6/5/2018Northcoast ResearchDowngradeBuy ➝ NeutralHigh
5/16/2018Deutsche Bank AktiengesellschaftLower Price TargetBuy$55.00Low
5/8/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$71.00High
5/8/2018Barrington ResearchLower Price TargetOutperform ➝ Outperform$70.00 ➝ $54.00High
5/8/2018BarclaysReiterated RatingHold$55.00High
5/8/2018Stifel NicolausReiterated RatingBuy ➝ Buy$67.00 ➝ $57.00High
5/8/2018HC WainwrightLower Price TargetNeutral ➝ Neutral$63.00 ➝ $52.00High
4/16/2018Jefferies Financial GroupReiterated RatingBuyLow
4/5/2018Cleveland ResearchReiterated RatingHoldLow
3/27/2018Barrington ResearchReiterated RatingBuy$69.00Medium
3/27/2018HC WainwrightSet Price TargetHold$63.00Medium
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$62.00Low
3/5/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$75.00 ➝ $70.00Low
3/5/2018Barrington ResearchReiterated RatingOutperform ➝ Outperform$73.00 ➝ $70.00Low
3/5/2018HC WainwrightSet Price TargetNeutral ➝ Hold$68.00 ➝ $63.00Medium
3/2/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$73.00 ➝ $69.00High
1/18/2018HC WainwrightReiterated RatingHold$68.00Low
1/5/2018Credit Suisse GroupDowngradeHold$73.00Medium
12/13/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$75.00Medium
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$81.00Low
12/7/2017HC WainwrightReiterated RatingHold$68.00Low
11/30/2017HC WainwrightDowngradeBuy ➝ Neutral$68.00Medium
11/28/2017StephensInitiated CoverageOverweight$75.00Low
11/6/2017Stifel NicolausBoost Price TargetBuy$66.00 ➝ $70.00N/A
11/6/2017HC WainwrightReiterated RatingBuy$68.00N/A
11/6/2017Barrington ResearchUpgradeMarket Perform ➝ Outperform$73.00N/A
10/19/2017Robert W. BairdSet Price TargetBuy$63.00N/A
10/19/2017Stifel NicolausReiterated RatingBuyN/A
10/6/2017Morgan StanleyReiterated RatingOverweight$67.00 ➝ $69.00N/A
10/5/2017Cleveland ResearchDowngradeBuy ➝ NeutralN/A
10/3/2017HC WainwrightReiterated RatingBuy$68.00Low
8/23/2017Jefferies Financial GroupLower Price TargetBuy$72.00 ➝ $66.00High
8/14/2017HC WainwrightReiterated RatingBuy ➝ Buy$74.00 ➝ $68.00Medium
8/10/2017UBS GroupReiterated RatingNeutral$62.00 ➝ $59.00Low
8/10/2017Morgan StanleyBoost Price TargetOverweight$66.00 ➝ $67.00Low
8/10/2017Stifel NicolausReiterated RatingBuy$70.00 ➝ $66.00Low
7/13/2017Credit Suisse GroupReiterated RatingOutperform$67.00 ➝ $75.00Low
7/11/2017HC WainwrightInitiated CoverageBuy ➝ Buy$74.00Low
5/23/2017Cleveland ResearchUpgradeNeutral ➝ BuyMedium
5/23/2017The Goldman Sachs GroupDowngradeNeutral ➝ Sell$60.00 ➝ $55.00Medium
2/21/2017Barrington ResearchDowngradeOutperform ➝ Market PerformN/A
2/13/2017Stifel NicolausUpgradeHold ➝ Buy$62.00 ➝ $70.00N/A
1/23/2017Jefferies Financial GroupLower Price TargetBuy$70.00 ➝ $68.00N/A
12/5/2016Barrington ResearchUpgradeMarket Perform ➝ Outperform$63.00N/A
11/7/2016UBS GroupReiterated RatingNeutral$64.00 ➝ $67.00N/A
11/1/2016Morgan StanleyUpgradeEqual Weight ➝ Overweight$65.00 ➝ $69.00N/A
10/4/2016Robert W. BairdReiterated RatingOutperform$69.00 ➝ $67.00N/A
9/22/2016JPMorgan Chase & Co.Initiated CoverageNeutral$65.00N/A
9/12/2016Bank of AmericaInitiated CoverageBuy$70.00N/A
8/17/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/8/2016Barrington ResearchDowngradeOutperform ➝ Market PerformN/A
6/28/2016UBS GroupReiterated RatingHoldN/A
6/27/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
6/26/2016Credit Suisse GroupReiterated RatingBuyN/A
(Data available from 6/23/2016 forward)
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Read More

Today's Range

Now: $64.07
Low: $63.10
High: $64.86

50 Day Range

MA: $66.43
Low: $63.18
High: $69.12

52 Week Range

Now: $64.07
Low: $40.15
High: $69.54


1,708,817 shs

Average Volume

1,576,705 shs

Market Capitalization

$13.99 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of DENTSPLY SIRONA?

The following Wall Street research analysts have issued research reports on DENTSPLY SIRONA in the last twelve months: Bank of America Co., Barclays PLC, Barrington Research, Guggenheim, HC Wainwright, JPMorgan Chase & Co., Piper Sandler, Robert W. Baird, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for XRAY.

What is the current price target for DENTSPLY SIRONA?

8 Wall Street analysts have set twelve-month price targets for DENTSPLY SIRONA in the last year. Their average twelve-month price target is $64.00, suggesting a possible downside of 0.1%. Robert W. Baird has the highest price target set, predicting XRAY will reach $78.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $47.00 for DENTSPLY SIRONA in the next year.
View the latest price targets for XRAY.

What is the current consensus analyst rating for DENTSPLY SIRONA?

DENTSPLY SIRONA currently has 1 sell rating, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XRAY, but not buy more shares or sell existing shares.
View the latest ratings for XRAY.

What other companies compete with DENTSPLY SIRONA?

How do I contact DENTSPLY SIRONA's investor relations team?

DENTSPLY SIRONA's physical mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier's listed phone number is 844-546-3722 and its investor relations email address is [email protected] The official website for DENTSPLY SIRONA is